Metabolic Abnormalities and Body Composition of HIV-infected Children on Lopinavir or Nevirapine-Based Antiretroviral Therapy

Archives of Disease in Childhood - United Kingdom
doi 10.1136/archdischild-2012-302633
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Relation of Body Composition to Body Mass Index in HIV-Infected Patients With Metabolic Abnormalities

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2008English

Random Lopinavir Concentrations Predict Resistance on Lopinavir-Based Antiretroviral Therapy

International Journal of Antimicrobial Agents
MedicineInfectious DiseasesMicrobiologyPharmacology
2016English

Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy Before the Age of Two in Cote D’Ivoire

PLoS ONE
Multidisciplinary
2016English

Long-Term Safety and Effectiveness of Lopinavir/Ritonavir in Antiretroviral-Experienced HIV-1-infected Children

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2010English

Growth in HIV-infected Children on Long-Term Antiretroviral Therapy

Tropical Medicine and International Health
EnvironmentalParasitologyInfectious DiseasesPublic HealthOccupational Health
2016English

Relationship of Body Composition, Metabolic Status, Antiretroviral Use, and HIV Disease Factors to Endothelial Dysfunction in HIV-Infected Subjects

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2010English

The Frequency of Malaria Is Similar Among Women Receiving Either Lopinavir/Ritonavir or Nevirapine-Based Antiretroviral Treatment

PLoS ONE
Multidisciplinary
2012English

Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/R Based Antiretroviral Therapy

PLoS ONE
Multidisciplinary
2013English

Response of HIV-associated Proteinuria to Antiretroviral Therapy in HIV-1-infected Children

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy